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Background
Malignant hyperthermia (MH), central core disease
(CCD), exertional heat stroke (EHS) and late-onset axial
myopathy have been attributed to mutations in ryanodine
receptor type 1 (RYR1). The RyR1 protein is over 5000
amino acid residues long, making manipulation of the
mammalian gene difficult. The ryanodine receptor in
Caenorhabditis elegans is UNC-68, which has 40% amino
acid identity to the human protein.
Material and methods and results
Due to the compact nature of the C. elegans genome,
the unc-68 gene is only 27 kb and is entirely contained
in the fosmid clone WRM069cA02. Using recombineer-
ing, single base pairs were changed in this fosmid to
establish nine different variants:





• One implicated in EHS:
○ p.R163C c.487C>T
• Two implicated in CCD:
○ p.R4861H c.14582G>A
○ p.A4940T c.14820G>A
• Two implicated in Late-onset axial myopathy:
○ p.K3452Q c.10354A>C
○ pV4849I c.14545G>A
Using these altered fosmids, transgenic strains were
developed by microinjection.
In order to establish these strains as a suitable model for
studying RYR1 variants phenotyping assays were completed
to assess the effects of halothane and caffeine on each of the
strains developed. The rationale for this approach is based
on the in vitro contracture test (IVCT). Both halothane and
caffeine assays were carried out in S-medium. 1mM,
1.5mM, 2.0mM, 2.5mM concentrations of halothane were
used, with halothane dissolved in DMSO prior to dilution
in a liquid medium. The lowest concentration used is the
lowest dose of halothane that will fully anaesthetise the
worms and the highest dose is the maximum dosage from
which worms can recover. Worms were immersed for
60 seconds and then body bends counted. 5mM, 10mM,
20mM, 40mM and 80mM concentrations of caffeine were
used. Worms were immersed for 5 minutes and then body
bends counted. This provided a measure of the effect of
these chemicals on locomotion.
Conclusions
Additional work will focus on examining the effect of age
on the muscle of these transgenic strains. I will present
the methods used to generate transgenic worms for each
variant expressing gfp-myosin. This process involves mat-
ing strains to produce unc-68 worms expressing gfp, UV
mutagenesis of this strain and then subsequent mating of
the resultant strain with each of the muscle myopathy var-
iant strains to introduce the gfp-myosin tag. This will
enable visual examination of the muscle at different stages
of the worm’s lifespan. I will demonstrate the way in
which ageing will be assessed and how it will be possible
to interpret the age related changes that occur in the mus-
cle and analyse this information for any potential effect of
the variant on the ageing process.
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